Skip to main content

Advertisement

Log in

Subacute progression of human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis

  • Short Communication
  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

Although human T-lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is usually described as a chronic disabling disease, a rapid course over months or even weeks has been reported in some patients. The authors describe the clinical features of HAM/TSP in a Brazilian cohort and evaluate the prevalence of patients with a subacute progression of the disease. This was defined as the requirement of a wheelchair during the first 2 years after the onset of symptoms. Patients with this subacute course and patients with the chronic clinical course were compared in terms of their HTLV-I proviral loads (PLs) using real-time polymerase chain reaction (PCR). Seven out of 88 patients (7.9%) had a subacute progression. All patients were women and 5/7 acquired HTLV-I through sexual contact. There was no significant difference in the real-time PLs between the group with subacute evolution (mean 8.5 copies/100 cells, range 6.03 to 12.09) and those patients with a typical course of disease (mean 11.34 copies/100 cells, range 0.4 to 67.72) (P = .68), suggesting that factors other than the number of infected cells are implicated in the development of such an aggressive course of disease. Early recognition of this subgroup is important because immunosuppressive treatment might be beneficial if instituted promptly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Araujo AQ, Afonso CR, Leite AC, Dultra SV (1993). Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). Arq Neuropsiquiatr 51: 325–328.

    CAS  PubMed  Google Scholar 

  • Araujo AQ, Andrade-Filho AS, Castro-Costa CM, Menna-Barreto M, Almeida SM (1998). HTLV-I-associated myelopathy/tropical spastic paraparesis in Brazil: a nationwide survey. HAM/TSP Brazilian Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 19: 536–541.

    CAS  PubMed  Google Scholar 

  • Araujo AQ, Silva MT (2006). The HTLV-1 neurological complex. Lancet Neurol 5: 1068–1076.

    Article  CAS  PubMed  Google Scholar 

  • Carod-Artal FJ, Vazquez-Cabrera C (2000). [Rapidly progressive myelopathy due to human lymphotropic virus (HTLV-1)]. Rev Neurol 30: 98–99.

    CAS  PubMed  Google Scholar 

  • Castillo LC (ed). (1989). Spastic paraparesis and HTLV-I in the Republic of Panama, Vol.-, edn. New Yok: Alan R. Liss.

    Google Scholar 

  • Cruickshank JK, Rudge P, Dalgleish AG, Newton M, McLean BN, Barnard RO, Kendall BE, Miller DH (1989). Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. Brain 112(Pt 4): 1057–1090.

    Article  PubMed  Google Scholar 

  • de The G, Bomford R (1993). An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses 9: 381–386.

    Article  PubMed  Google Scholar 

  • Gessain A, Gout O (1992). Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 117: 933–946.

    CAS  PubMed  Google Scholar 

  • Gotuzzo E, Cabrera J, Deza L, Verdonck K, Vandamme AM, Cairampoma R, Vizcarra D, Cabada M, Narvarte G, De las Casas C (2004). Clinical characteristics of patients in peru with human T cell lymphotropic virus type 1associated tropical spastic paraparesis. Clin Infect Dis 39: 939–944.

    Article  CAS  PubMed  Google Scholar 

  • Gout O, Baulac M, Gessain A, Semah F, Saal F, Peries J, Cabrol C, Foucault-Fretz C, Laplane D, Sigaux F, et al (1990). Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 322: 383–388.

    Article  CAS  PubMed  Google Scholar 

  • Harrington WJ Jr, Sheremata WA, Snodgrass SR, Emerson S, Phillips S, Berger JR (1991). Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/ HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retroviruses 7: 1031–1034.

    Article  PubMed  Google Scholar 

  • Iwasaki Y (1990). Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 96: 103–123.

    Article  CAS  PubMed  Google Scholar 

  • Jacobson S (2002). Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 186 (Suppl 2): S187-S192.

    Article  PubMed  Google Scholar 

  • Kida H, Nakagawa M, Iwasaki H, Moritoyo T, Kawabata M, Arimura K, Osame M (1997). [A case of rapidly progressive HTLV-I-associated myelopathy (HAM)]. Rinsho Shinkeigaku 37: 802–805.

    CAS  PubMed  Google Scholar 

  • Kiwaki T, Umehara F, Arimura Y, Izumo S, Arimura K, Itoh K, Osame M (2003). The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy. J Neurol Sci 206: 17–21.

    Article  CAS  PubMed  Google Scholar 

  • Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S (2000). Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. AIDS Res Hum Retroviruses 16: 1705–1709.

    Article  CAS  PubMed  Google Scholar 

  • Kuroda Y, Fujiyama F, Nagumo F (1991a). Analysis of factors of relevance to rapid clinical progression in HTLV-I-associated myelopathy. J Neurol Sci 105: 61–66.

    Article  CAS  PubMed  Google Scholar 

  • Kuroda Y, Takashima H, Ikeda A, Endo C, Neshige R, Kakigi R, Shibasaki H (1991b). Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin. J Neurol 238: 309–314.

    Article  CAS  PubMed  Google Scholar 

  • Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, Garratty G, Murphy EL (2006). Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis 194: 1557–1564.

    Article  PubMed  Google Scholar 

  • Leite AC, Silva MT, Alamy AH, Afonso CR, Lima MA, Andrada-Serpa MJ, Nascimento OJ, Araujo AQ (2004). Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy. J Neurol 251: 877–881.

    Article  PubMed  Google Scholar 

  • Lima MA, Bica RB, Araujo AQ (2005). Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis. J Neurol Neurosurg Psychiatry 76: 294–296.

    Article  CAS  PubMed  Google Scholar 

  • Madeleine MM, Wiktor SZ, Goedert JJ, Manns A, Levine PH, Biggar RJ, Blattner WA (1993). HTLV-I and HTLV-II world-wide distribution: reanalysis of 4,832 immunoblot results. Int J Cancer 54: 255–260.

    Article  CAS  PubMed  Google Scholar 

  • Maloney EM, Cleghorn FR, Morgan OS, Rodgers-Johnson P, Cranston B, Jack N, Blattner WA, Bartholomew C, Manns A (1998). Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol 17: 167–170.

    CAS  PubMed  Google Scholar 

  • Manns A, Hisada M, La Grenade L (1999). Human T-lymphotropic virus type I infection. Lancet 353: 1951–1958.

    Article  CAS  PubMed  Google Scholar 

  • Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, Kubota H, Izumo S, Akiba S, Osame M (2001). HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J NeuroVirol 7: 228–234.

    Article  CAS  PubMed  Google Scholar 

  • Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M (1998). Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J NeuroVirol 4: 586–593.

    Article  CAS  PubMed  Google Scholar 

  • Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M (1995). HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J NeuroVirol 1: 50–61.

    Article  CAS  PubMed  Google Scholar 

  • Nakamura T, Shibayama K, Nagasato K, Matsuo H, Tsujihata M, Nagataki S (1990). The efficacy of interferon-alpha treatment in human T-lymphotropic virus type-I-associated myelopathy. Jpn J Med 29: 362–367.

    CAS  PubMed  Google Scholar 

  • Olindo S, Cabre P, Lezin A, Merle H, Saint-Vil M, Signate A, Bonnan M, Chalon A, Magnani L, Cesaire R, Smadja D (2006). Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study. Arch Neurol 63: 1560–1566.

    Article  PubMed  Google Scholar 

  • Olindo S, Lezin A, Cabre P, Merle H, Saint-Vil M, Edimonana Kaptue M, Signate A, Cesaire R, Smadja D (2005). HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression. J Neurol Sci 237: 53–59.

    Article  PubMed  Google Scholar 

  • Osame M (1990). Review of WHO Kagoshima Meeting and Diagnostic Guidelines for HAM/TSP, 1 ed. New York: Raven Press.

    Google Scholar 

  • Roman GC, Spencer PS, Schoenberg BS, Hugon J, Ludolph A, Rodgers-Johnson P, Osuntokun BO, Shamlaye CF (1987). Tropical spastic paraparesis in the Seychelles Islands: a clinical and case-control neuroepidemiologic study. Neurology 37: 1323–1328.

    CAS  PubMed  Google Scholar 

  • Shakudo M, Inoue Y, Tsutada T (1999). HTLV-Iassociated myelopathy: acute progression and atypical MR findings. AJNR Am J Neuroradiol 20: 1417–1421.

    CAS  PubMed  Google Scholar 

  • Silva MT, Araujo A (2004). Spinal cord swelling in human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis: magnetic resonance indication for early anti-inflammatory treatment? Arch Neurol 61: 1134–1135.

    Article  PubMed  Google Scholar 

  • Tateno M, Kondo N, Itoh T, Chubachi T, Togashi T, Yoshiki T (1984). Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization. J Exp Med 159: 1105–1116.

    Article  CAS  PubMed  Google Scholar 

  • Taylor GP, Tosswill JH, Matutes E, Daenke S, Hall S, Bain BJ, Davis R, Thomas D, Rossor M, Bangham CR, Weber JN (1999). Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr 22: 92–100.

    CAS  PubMed  Google Scholar 

  • Watanabe M, Yamashita T, Hara A, Murakami T, Ando Y, Uyama E, Mita S, Uchino M (2001). High signal in the spinal cord on T2-weighted images in rapidly progressive tropical spastic paraparesis. Neuroradiology 43: 231–233.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco A. Lima.

Additional information

This work was supported by CNPq (Brazilian National Research Council), Fundação Oswaldo Cruz and the Brazilian Ministry of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lima, M.A., Harab, R.C., Schor, D. et al. Subacute progression of human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. Journal of NeuroVirology 13, 468–473 (2007). https://doi.org/10.1080/13550280701510096

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/13550280701510096

Keywords

Navigation